ArcBest director granted 1,350 company shares
ArcBest Corp. director Salvatore A. Abbate received a stock grant in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ArcBest Corp. director Salvatore A. Abbate received a stock grant in the company. On May 5, 2026, he acquired 1,350 shares of ArcBest common stock through a grant, award, or similar acquisition at a stated price of $0.00 per share.
After this transaction, Abbate directly holds 7,725 shares of ArcBest common stock. The filing reports no related derivative securities, so this event reflects a straightforward increase in his directly owned common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.01 per share | 1,350 | $0.00 | $0.00 |
Key Figures
Key Terms
Form 4 regulatory
Grant, award, or other acquisition financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ArcBest (ARCB) director Salvatore A. Abbate report on this Form 4?
Was the ArcBest (ARCB) transaction by Salvatore A. Abbate a market purchase or a grant?
Does the ArcBest (ARCB) Form 4 show any stock options or other derivatives for Salvatore A. Abbate?
Is Salvatore A. Abbate reported as a director or officer of ArcBest (ARCB) in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.